We are excited to announce that the 11th World Congress on Infectious Diseases (WCID - 2026) will take place from April 15th to 17th, 2026, in the historic city of Athens. Building on the success of previous editions, WCID - 2026 aims to bring together leading scientists, researchers, healthcare professionals, and policymakers from around the world. This gathering serves as a premier platform for sharing the latest research findings, discussing innovative strategies, and fostering collaborations in the fight against infectious diseases.
Athens, with its rich cultural heritage and vibrant academic environment, provides an ideal backdrop for this important event. Participants can look forward to a stimulating program featuring keynote speeches, plenary sessions, oral presentations, and poster displays. The congress will cover a wide range of topics related to infectious diseases, including emerging pathogens, vaccine development, disease prevention and control, and global health challenges.
Whether you are a seasoned expert or new to the field, WCID - 2026 offers a unique opportunity to network with colleagues, learn from the best in the industry, and contribute to the advancement of infectious disease research and practice. We look forward to welcoming you to Athens in 2026!
◆ 9 Parallel Meetings – Focused Discussions on Cutting-Edge Biomedicine
◆ 40+ Breakout Sessions – In-Depth Explorations Across 3 Days
◆ 10+ Exhibitors & Posters – Showcasing the Latest Innovations
◆ 350+ Oral Presentations – Covering Breakthrough Research and Emerging Technologies
◆ 500+ Attendees – Unparalleled Networking for Collaboration and Growth
 |
 |
|
|
Dr. Efstathios P. Efstathopoulos, Vice Rector of Research and Innovation; Professor of Medical Physics, National and Kapodistrian University of Athens, Greece |
Dr. Ved Srivastava, CTO, Perpetual Medicine, USA; President, Global Peptide Science Institute, USA |
|
 |
 |
 |
|
|
Dr. Jesper Lau, Vice President, Protein and Peptide Chemistry, Novo Nordisk A/S, Denmark |
Dr. Laszlo Takacs, Professor, University of Debrecen; CEO/CSO Biosystems Immunolab Zrt, Hungary; Foreign Member of the Hungarian Academy of Sciences |
Dr. Paul A. Insel, Distinguished Professor of Pharmacology and Medicine, Co-Director, Medical Scientist (MD/PhD) Training Program, University of California San Diego, USA |
|
 |
 |
 |
|
|
Dr. Megan Gibbs, Vice President, Global Head of Clinical Pharmacology and Quantitative Pharmacology, AstraZeneca, USA |
Dr. Hans-Jürgen Federsel, Senior Advisor, RISE Research Institutes of Sweden, Sweden; Fellow of the Royal Swedish Academy of Engineering Sciences |
Dr. Eyal Talor, Chief Scientific Officer, CEL-SCI Corporation, USA; Johns Hopkins, Medical Institutions, USA |
 |
 |
 |
| Dr. Roman A. Zubarev, Professor of Medicinal Proteomics, Karolinska Institutet, Sweden |
Dr. Ivo Timmermans, Chief Executive Officer, Pleco Therapeutics BV, the Netherlands |
Dr. Fathi Moussa, Professor, University Paris-Sud, France |
 |
 |
 |
| Dr. K. Eric Paulson, Co-Founder, Cha Therapeutics, Inc., USA |
Dr. Vuong Trieu, CEO, Oncotelic Therapeutics, USA |
Dr. Faz Chowdhury, CEO and Chairman, Nemaura Pharma Limited, UK |
 |
 |
 |
| Dr. Kevin Hicok, Vice President of Research and Development, Direct Biologics LLC, USA |
Dr. Hassan M. Heshmati, Consultant in Endocrinology and Metabolism, Endocrinology Metabolism Consulting, LLC, USA |
Mr. Lamine Messaoudi, Head of Regulatory Policy and Innovation EUCAN, Takeda, Japan |
 |
 |
 |
| Dr. Anders Dahlén, Director, Oligo Chemistry Team, AstraZeneca, Sweden |
Dr. Fuad Fares, Professor, Head of Molecular Genetics Laboratory, University of Haifa, Israel |
Mr. Romit Jani, Director of Formulation, Solaris Pharma Corporation, USA |
 |
 |
 |
| Dr. Remya Mohanraj, Professor, Faculty Biology, OER Coordinator, Houston Community College, USA |
Dr. Vesna Miskovic-Stankovic, Professor, University Union-Nikola Tesla, Serbia |
Dr. Andrey Koptyug, Associate Professor, Mid Sweden University, Sweden |
 |
 |
 |
| Dr. Hanadi Bakr A. Baghdadi, Imam Abdulrahman Bin Faisal University, Saudi Arabia |
Dr. Winston Dunn, Associate Professor of Medicine, University of Kansas, USA |
Dr. Boniface Matadi Maba, Associate Professor, University of Zululand, South Africa |
WCID - 2026 will be hosted in Athens, Greece, from April 15th to 17th, 2026. This ancient city, with over 3,400 years of recorded history, birthed democracy and was home to great philosophers. Athens features iconic landmarks like the Acropolis and the Parthenon, along with a rich collection of artifacts at the National Archaeological Museum. Strategically located in southeastern Greece near the Mediterranean Sea, it has a well - connected international airport. As Greece's economic and cultural heart, Athens blends traditional industries like olive cultivation with modern sectors, and its vibrant streets offer diverse dining and shopping experiences for conference attendees.
● Speaking Proposals are Now being Accepted, Submit the Abstract Right Now
● REGISTER NOW to secure your attendance
● Program will be released soon
● Call for co-organizers, supporting organizations
● Call for collaborative partners, media and journal
● Call for exhibitors, and posters
World High Technology Society
Copyright © 2003-2026 BIT Congress Inc.
Contact us: jodie.jiang@gala-loc.com